A radiomic signature as a non-invasive predictor of progression-free survival in patients with lower-grade gliomasXing Liu, Yinyan Wang, Yiming Li et al.|NeuroImage Clinical|2018Cited by 262
Genotype prediction of ATRX mutation in lower-grade gliomas using an MRI radiomics signatureYiming Li, Tao Jiang, Xing Liu et al.|European Radiology|2018Cited by 122
Radiogenomics of lower-grade gliomas: a radiomic signature as a biological surrogate for survival predictionZenghui Qian, Yinyan Wang, Yiming Li et al.|Aging|2018Cited by 40
WES data from 286 diffuse gliomas under the 2021 WHO Classification of Tumors of the Central Nervous SystemZheng Zhao, Tao Jiang, Kenan Zhang et al.|Scientific Data|2022Cited by 17
Molecular Characterization and Clinical Relevance of ANXA1 in Gliomas via 1,018 Chinese Cohort PatientsZenghui Qian, Zheng Zhao, Wenhua Fan et al.|Frontiers in Cell and Developmental Biology|2021Cited by 15